News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,636 Results
Type
Article (40899)
Company Profile (267)
Press Release (680460)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204662)
Career Advice (2023)
Deals (35532)
Drug Delivery (110)
Drug Development (81380)
Employer Resources (173)
FDA (16408)
Job Trends (14944)
News (346375)
Policy (32725)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2567)
Accelerated approval (31)
Adcomms (24)
Allergies (142)
Alliances (49575)
ALS (169)
Alzheimer's disease (1667)
Antibody-drug conjugate (ADC) (308)
Approvals (16677)
Artificial intelligence (513)
Autoimmune disease (153)
Automation (39)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (637)
Cancer (4792)
Cardiovascular disease (398)
Career advice (1708)
Career pathing (36)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (739)
Cervical cancer (36)
Clinical research (69553)
Collaboration (1695)
Company closure (4)
Compensation (1156)
Complete response letters (54)
COVID-19 (2710)
CRISPR (88)
C-suite (841)
Cystic fibrosis (143)
Data (6211)
Decentralized trials (2)
Denatured (25)
Depression (131)
Diabetes (499)
Diagnostics (6686)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (251)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (90150)
Editorial (56)
Employer branding (21)
Employer resources (152)
Events (117264)
Executive appointments (971)
FDA (19516)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1465)
Gene editing (194)
Generative AI (43)
Gene therapy (593)
GLP-1 (965)
Government (4659)
Grass and pollen (6)
Guidances (383)
Healthcare (18872)
HIV (58)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (249)
Immuno-oncology (57)
Indications (110)
Infectious disease (2978)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (248)
Interviews (315)
IPO (16642)
IRA (50)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (85)
Layoffs (546)
Leadership (31)
Legal (7949)
Liver cancer (91)
Longevity (14)
Lung cancer (645)
Lymphoma (375)
Machine learning (42)
Management (59)
Manufacturing (790)
MASH (163)
Medical device (13767)
Medtech (13820)
Mergers & acquisitions (19960)
Metabolic disorders (1264)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (314)
Neuropsychiatric disorders (88)
Neuroscience (2890)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4514)
Now hiring (67)
Obesity (593)
Opinion (257)
Ovarian cancer (166)
Pain (197)
Pancreatic cancer (226)
Parkinson's disease (279)
Partnered (33)
Patents (494)
Patient recruitment (487)
Peanut (56)
People (58861)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21683)
Phase 2 (30612)
Phase 3 (22803)
Pipeline (5256)
Policy (281)
Postmarket research (2564)
Preclinical (9196)
Press Release (64)
Prostate cancer (237)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (831)
Real estate (5954)
Recruiting (70)
Regulatory (24470)
Reports (52)
Research institute (2387)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (147)
Series A (238)
Series B (190)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3614)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (1001)
Venture capital (88)
Weight loss (379)
Women's health (91)
Worklife (18)
Date
Today (200)
Last 7 days (618)
Last 30 days (2127)
Last 365 days (29974)
2026 (3365)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39215)
Australia (6410)
California (11270)
Canada (3280)
China (1095)
Colorado (477)
Connecticut (475)
Delaware (335)
Europe (84499)
Florida (1685)
Georgia (354)
Hawaii (3)
Idaho (61)
Illinois (857)
India (65)
Indiana (519)
Iowa (22)
Japan (428)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1380)
Massachusetts (8075)
Michigan (324)
Minnesota (628)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2996)
New Mexico (28)
New York (2969)
North Carolina (1447)
North Dakota (8)
Northern California (5506)
Ohio (332)
Oklahoma (21)
Oregon (41)
Pennsylvania (2275)
Puerto Rico (24)
Rhode Island (47)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4385)
Tennessee (174)
Texas (1737)
United States (39940)
Utah (334)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (918)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
721,636 Results for "vaxxas inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
January 8, 2026
·
5 min read
Press Releases
Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market
November 11, 2025
·
5 min read
Press Releases
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
August 25, 2025
·
7 min read
Press Releases
Vaxxas Secures New U.S. Patent For its Needle-Free Vaccination Manufacturing Technology
March 19, 2025
·
5 min read
Press Releases
Vaxxas Completes Enrollment for Largest Clinical Trial of High-Density Microarray Patch (HD-MAP) For Vaccine Delivery
February 18, 2025
·
6 min read
Press Releases
Vaxxas Appoints Leading Global Vaccine Experts as the Company Advances its Needle-Free Vaccination Technology Towards Late-Stage Clinical Trials
February 6, 2025
·
6 min read
Press Releases
Vaxxas and CEPI Advance US$4.8 million (AU$7.2 million) Program for Needle-Free Thermostable mRNA Vaccines
January 23, 2025
·
8 min read
Press Releases
Vaxxas Expands Global Intellectual Property Portfolio for Exclusive Manufacture and Sale of Needle-Free Vaccination Technology
November 25, 2024
·
5 min read
Press Releases
Newly Published Data Supports Effective Delivery of DNA-Based Vaccines Using Vaxxas’ High-Density Microarray Patch (HD-MAP) Delivery Technology
March 5, 2025
·
8 min read
Press Releases
Vaxxas Initiates Phase I Clinical Trial of Pre-Pandemic Avian Influenza A Virus (H7N9) Vaccine Delivered Using Vaxxas’ Novel High-Density Microarray Patch (HD-MAP)
September 11, 2024
·
6 min read
1 of 72,164
Next
